Quick Links
 

CTSA

The NIH Common Fund announces FY2020 funding opportunities for the NIH Director’s Pioneer Award, New Innovator Award, Transformative Research Award, and Early Independence Award in the High-Risk, High-Reward Research program. The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address...

This translational endeavor aims to partner clinical proficiencies throughout the CTSA network with drug discovery resources. CTSA-affiliated researchers and clinicians who have identified potential drug targets, pathways or screening approaches and are interested in accelerated translation into patients through drug repurposing are encouraged to respond....

Are you conducting multi-site clinical research? If so, there are opportunities for collaboration with the Trial Innovation Network and its partner the Recruitment Innovation Center. The vision for the Trial Innovation Network is to innovatively address critical roadblocks in clinical research and accelerate the translation...

NCATS has announced funding opportunities to use partially developed therapeutic candidates (also known as assets) to identify new treatments for a broad range of diseases. Through the templates for research agreements between academic institutions and pharmaceutical companies, the New Therapeutic Uses program significantly shortens the...

The 2019 Spring CTSA Program Group Meetings will be taking place March 4 – 5, 2019 at the Marriott Wardman Park Hotel in Washington, D.C. Established meetings: Collaboration & Engagement DTF Communications Methods & Processes DTF KL2 Principal Investigators TL1 Principal Investigators Workforce Development DTF Additional...

CLIC has been working to create and implement a website tool to foster collaboration and communication among the CTSA Program consortium. The CLIC Forum is now live. One of the goals of the CTSA Program is to encourage team science and to tackle system-wide scientific and...

The GGACT cooperative, a collaboration between Boston Children’s Hospital, Cincinnati Children’s Hospital Medical Center, and the University of California Los Angeles, was established to support investigators in rapidly translating complex gene and cell therapies to early phase, investigator-initiated clinical trials by providing expertise in protocol...

The NIH announces this year's Lasker Clinical Research Scholars Program. This is a competitive opportunity for early-stage physician-scientists to conduct independent clinical and translational research as tenure-track investigators at the NIH and in academia. It was established in 2011 to create career research opportunities for...

CTSI leaders and scholars recently returned from attending the Association for Clinical and Translational Science 2018 Conference in Washington D.C. where they networked with colleagues, researchers, scholars, industry leaders, and NCATS program officers and attended exciting and innovative sessions on topics related to Clinical and...

NCATS and Eli Lilly are accepting applications for the third round of its externship program. This 6 month externship aims to increase the skill sets of translational science trainees in drug development and to learn from another sector in the translational research ecosystem. NCATS continues...

The collaborative efforts of two Wisconsin NIH funded CTSA partnering entities results in a $5,360,832 National Institute of Health’s (NIH’s) All of Us Research grant that will benefit communities across the state of Wisconsin and the country.   Marshfield Clinic Research Institute, University of Wisconsin School of Medicine and...

NCATS Office of Rare Diseases Research (ORDR) will be hosting a webinar on the European Reference Network on Rare Neurological Diseases (ERN-RND) on Wednesday, Sept. 13, 2017. Holm Graessner, Ph.D., MBA, Coordinator, ERN-RND, and Enrique Terol of the European Commission will be presenting. Please save the...

NIH achieves milestone to accelerate multisite clinical studies CTSA Program paves way for nationwide single IRB model Funded by NCATS, SMART IRB is designed to streamline the IRB ethical review process for multisite studies ranging from two sites to over one hundred. With SMART IRB, institutions can designate one...

We wanted to pass on the following two opportunities. Please distribute far and wide. Please see the attached slide set and handouts summarizing BRAIN Human Research Opportunities. Brief summary is as follows: BRAIN PPP for Human Device Development - for partnerships between clinical investigators and manufacturers of the...

The Medical College of Wisconsin (MCW) has been awarded a five-year, $20 million Clinical and Translational Science Award from the National Institutes of Health. This competitive grant renewal will fund the work of the Clinical and Translational Science Institute of Southeastern Wisconsin (CTSI), a consortium...

NIH Funding Acknowledgment: Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.

PARTNERS

VersitiChildren's Hospital of WisconsinVA Medical CenterMarquette UniversityMSOEUWM